These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38324017)

  • 21. Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome.
    Horie S; Laffey JG
    F1000Res; 2016; 5():. PubMed ID: 27408702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.
    Masterson C; Jerkic M; Curley GF; Laffey JG
    Minerva Anestesiol; 2015 Feb; 81(2):179-94. PubMed ID: 24492665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.
    Wang YY; Li XZ; Wang LB
    Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
    Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R
    Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
    Qu W; Wang Z; Hare JM; Bu G; Mallea JM; Pascual JM; Caplan AI; Kurtzberg J; Zubair AC; Kubrova E; Engelberg-Cook E; Nayfeh T; Shah VP; Hill JC; Wolf ME; Prokop LJ; Murad MH; Sanfilippo FP
    Stem Cells Transl Med; 2020 Sep; 9(9):1007-1022. PubMed ID: 32472653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
    Moll G; Drzeniek N; Kamhieh-Milz J; Geissler S; Volk HD; Reinke P
    Front Immunol; 2020; 11():1091. PubMed ID: 32574263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges.
    Cao C; Zhang L; Liu F; Shen J
    J Inflamm Res; 2022; 15():5235-5246. PubMed ID: 36120184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.
    Gotts JE; Abbott J; Matthay MA
    Am J Physiol Lung Cell Mol Physiol; 2014 Sep; 307(5):L395-406. PubMed ID: 25038188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats.
    Chen X; Wu S; Tang L; Ma L; Wang F; Feng H; Meng J; Han Z
    J Cell Physiol; 2019 May; 234(5):7301-7319. PubMed ID: 30362554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.
    Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fresh and Cryopreserved Human Umbilical-Cord-Derived Mesenchymal Stromal Cells Attenuate Injury and Enhance Resolution and Repair following Ventilation-Induced Lung Injury.
    Horie S; Gonzalez H; Brady J; Devaney J; Scully M; O'Toole D; Laffey JG
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice.
    Cai SX; Liu AR; Chen S; He HL; Chen QH; Xu JY; Pan C; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
    Stem Cell Res Ther; 2015 Apr; 6(1):65. PubMed ID: 25889393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges.
    Wang Z; Yu T; Hou Y; Zhou W; Ding Y; Nie H
    Curr Pharm Des; 2022; 28(27):2234-2240. PubMed ID: 35796453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS.
    Aitong W; Leisheng Z; Hao Y
    Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
    Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
    Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial.
    Grégoire C; Layios N; Lambermont B; Lechanteur C; Briquet A; Bettonville V; Baudoux E; Thys M; Dardenne N; Misset B; Beguin Y
    Front Immunol; 2022; 13():932360. PubMed ID: 35860245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.